Jpmorgan Chase & Co »

United Therapeutics Corp Del Call shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of United Therapeutics Corp Del Call shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in United Therapeutics Corp Del Call

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corp Del Call held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corp Del Call by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 5.4k 419.21
2025-03-31 $4.0M 13k 308.27
2024-06-30 $6.4M 20k 318.55
2024-03-31 $4.6M 20k 229.72
2023-03-31 $4.3M 19k 223.96
2018-03-31 $3.4M 30k 112.37

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding United Therapeutics Corp Del Call

IMC-Chicago
Group One Trading
Simplex Trading
Jpmorgan Chase & Co

View all funds holding United Therapeutics Corp Del Call